25 Novel antibodies for identification, selection, and manipulation of T cells expressing Whitlow linker-containing CARs
Erik L. Kimble(University of Washington), Cameron J. Turtle(The University of Sydney), Brandon Seaton(Fred Hutch Cancer Center), Aiko Torkelson(Fred Hutch Cancer Center), Alexandre V. Hirayama(University of Washington), Delaney Kirchmeier(Fred Hutch Cancer Center), Norman Boiani, Eric M. Tam(Fred Hutch Cancer Center), Cecilia C.S. Yeung(University of Washington), Jocelyn H. Wright(Fred Hutch Cancer Center), Jason Price, Ray Ruff, Kristina Braathen(Fred Hutch Cancer Center), David Jellyman(Fred Hutch Cancer Center), Kristin Shimp(Fred Hutch Cancer Center), Jordan Gauthier(Seattle Cancer Care Alliance)
Cited by 0
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy
|Blood|2017|1.1k
Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
|Blood|2016|743
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
|Nature Biotechnology|2017|623